Bluebird’s Latest Gene Therapy Stumble Will Help Vertex Close The Gap

Gene Therapy Launch Delayed Again

 
• By Andrew McConaghie
Bluebird bio
Bluebird's Zynteglo is delayed again, and may not reach its first market until 2022. • Source: Alamy

More from Business

More from Scrip